Institutional investors hold a majority ownership of ZTS through the 94.40% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2015, these large investors purchased a net $3.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY INVESTMENT MANAGE... Bought 6.2 Million shares of Zoetis Inc
POINT72 ASSET MANAGEMENT LP Bought 4.1 Million shares of Zoetis Inc
DEUTSCHE ASSET & WEALTH MANAGEME... Bought 2.1 Million shares of Zoetis Inc